League reportedly concludes Jalen Hurts's blood clot "was handled appropriately" before Week 5 game
Key Points:
- The NFL has decided not to take any action against the Philadelphia Eagles regarding their handling of Jalen Hurts' blood clot before Week 5, concluding the situation was managed appropriately.
- The Eagles maintained communication with the NFL throughout Hurts' evaluation, which included involvement from the NFL’s chief medical officer and a joint assessment at the Cleveland Clinic in London.
- Despite reports suggesting Hurts was advised not to sleep, sources confirm he rested adequately before playing, and the team did not violate injury reporting rules concerning his availability or the nature of his injury.
- The case highlights ongoing concerns about player healthcare in the NFL, suggesting a focus on meeting league requirements to keep players available rather than prioritizing comprehensive medical treatment.
- Questions remain about transparency, player health management, and potential misuse of inside information, with limited response from the NFL Players Association and unresolved issues likely to fade amid future league developments.